Want to join the conversation?
$MNK's net sales for FY15 jumped 60.8% from last year. This increase was primarily on inclusion of sales from Acthar, Ofirmev and Inomax. Specialty Generics sales increased due to higher sales of hydrocodone-related products and inclusion of full year of sales from BioVectra, partially offset by decreased sales of Methylphenidate ER.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.